Sona Nanotech Inc C.SONA

Alternate Symbol(s): SNANF

Technology Scientific & Technical Instruments

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.

CSE:SONA - Post by User

Sona Nanotech Inc > Why I think approval will be on Nov 4.

<< Previous

Bullboard Posts

Next >>

Comment by Devious66on Oct 28, 2020 12:44pm

184 Views

Post# 31796085

RE:RE:RE:Why I think approval will be on Nov 4.

We can toss out all the numbers and dates we want it's not gonna matter. It gets done when it gets done ! It's frustrating as hell and I for one am upset the company hasn't given any updates but I guess it's hard to give an update if they are being left in the dark as well. The fact a Canadian company with this good of a test is not already approved by HC is embarrassing. FDA would have approved this a month ago if it was an American company

<< Previous

Bullboard Posts

Next >>

Fobi AI responds to cease trade order, filing delay “disappointing”